【瞩目】2500万喜提1类新药,消化溃疡龙头掘金新市场

米内网
Jun 30, 2025

精彩内容近日,丽珠医药发布公告称,公司的1类新药YJH-012注射液获批临床,目前集团在抗痛风制剂市场暂无产品上市,该新药有望为集团开拓新市场。作为治疗与胃酸分泌相关疾病的药物市场龙头集团,丽珠医药手握两个超10亿产品艾普拉唑肠溶片和注射用艾普拉唑钠。表1:获批临床的新药情况来源:公司公告,米内网制表公告中提到,YJH-012注射液是丽珠医药与佑嘉(杭州)生物医药科技联合开发的新型siRNA药物,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10